Form 4 for KALA KALA BIO, Inc.
Accepted 2022-06-29 00:00:00 ET · period of report 2022-06-27 · accession 0001415889-22-007059 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-29 | 2022-06-27 | KALA | Iwicki Mark T | CEO, Dir | S - Sale | $0.37 | -7,975 | 251.2K | -3% | -$2,951 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-27 | S | D | 7,975 | $0.37 | 251,183 | D | — | — | (F1) This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of the reporting person's restricted stock units granted on June 25, 2020. (F2) Includes 139,819 unvested RSUs. |